PUGLIATTI, Maura
 Distribuzione geografica
Continente #
NA - Nord America 18.807
AS - Asia 13.456
EU - Europa 5.867
SA - Sud America 2.122
AF - Africa 303
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 40.599
Nazione #
US - Stati Uniti d'America 18.385
SG - Singapore 5.267
CN - Cina 3.041
BR - Brasile 1.653
VN - Vietnam 1.502
IT - Italia 1.247
HK - Hong Kong 1.199
UA - Ucraina 956
DE - Germania 917
TR - Turchia 614
GB - Regno Unito 553
FI - Finlandia 469
BD - Bangladesh 460
JP - Giappone 419
FR - Francia 418
SE - Svezia 330
RU - Federazione Russa 299
IN - India 228
MX - Messico 190
ID - Indonesia 174
AR - Argentina 171
CA - Canada 170
PL - Polonia 139
NL - Olanda 125
IQ - Iraq 99
ZA - Sudafrica 98
EC - Ecuador 81
PK - Pakistan 79
ES - Italia 76
EG - Egitto 66
CZ - Repubblica Ceca 60
UZ - Uzbekistan 57
VE - Venezuela 55
CO - Colombia 52
AT - Austria 47
SA - Arabia Saudita 40
MA - Marocco 39
CL - Cile 37
PH - Filippine 37
AU - Australia 29
MY - Malesia 28
PY - Paraguay 27
KE - Kenya 25
CH - Svizzera 23
IE - Irlanda 23
IR - Iran 22
BE - Belgio 21
PE - Perù 20
TN - Tunisia 20
AL - Albania 19
NP - Nepal 19
AE - Emirati Arabi Uniti 18
LT - Lituania 18
RO - Romania 18
JO - Giordania 16
IL - Israele 15
JM - Giamaica 15
DK - Danimarca 14
KZ - Kazakistan 14
DZ - Algeria 13
UY - Uruguay 13
AZ - Azerbaigian 12
DO - Repubblica Dominicana 12
MD - Moldavia 12
TH - Thailandia 12
BO - Bolivia 11
CY - Cipro 10
PS - Palestinian Territory 10
SI - Slovenia 10
HU - Ungheria 9
KR - Corea 9
NO - Norvegia 9
NZ - Nuova Zelanda 9
BG - Bulgaria 8
CR - Costa Rica 8
ET - Etiopia 8
HR - Croazia 8
OM - Oman 8
SN - Senegal 8
PT - Portogallo 7
TT - Trinidad e Tobago 7
KG - Kirghizistan 6
RS - Serbia 6
BH - Bahrain 5
GE - Georgia 5
GR - Grecia 5
HN - Honduras 5
NI - Nicaragua 5
PA - Panama 5
TW - Taiwan 5
AM - Armenia 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
GA - Gabon 4
KW - Kuwait 4
LB - Libano 4
LV - Lettonia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
Totale 40.551
Città #
Singapore 2.931
Ashburn 2.320
Fairfield 1.747
San Jose 1.254
Hong Kong 1.177
Chandler 1.148
Jacksonville 1.091
Woodbridge 979
Santa Clara 931
Beijing 791
Houston 719
Seattle 639
Wilmington 612
Cambridge 571
Nanjing 483
Ho Chi Minh City 470
Izmir 460
Tokyo 409
Hanoi 367
Ann Arbor 366
Dallas 324
Lauterbourg 311
New York 295
Princeton 288
Los Angeles 265
Boardman 253
Council Bluffs 239
Ferrara 207
San Diego 181
São Paulo 162
Helsinki 152
Nanchang 142
Mexico City 140
Warsaw 125
Munich 121
Milan 115
Jakarta 109
Shenyang 104
Chicago 102
Tianjin 98
Orem 93
Shanghai 89
Buffalo 88
Changsha 87
Rome 86
London 81
Hebei 77
Da Nang 71
Norwalk 65
Jiaxing 63
Montreal 61
Denver 59
Kunming 59
Bremen 57
Frankfurt am Main 57
Tashkent 54
Haiphong 52
Brooklyn 51
Hefei 51
Chennai 48
Bologna 47
Falls Church 47
Addison 45
Rio de Janeiro 45
Atlanta 44
Dearborn 44
Johannesburg 44
Cairo 42
Baghdad 41
Moscow 40
Stockholm 40
Brno 38
Nuremberg 37
Toronto 37
Belo Horizonte 36
Curitiba 36
Phoenix 36
Poplar 34
San Francisco 34
Falkenstein 33
Lahore 33
Lappeenranta 33
Turku 33
Jinan 32
Brasília 31
Amsterdam 29
Hải Dương 29
Biên Hòa 25
Vienna 25
Guayaquil 24
Istanbul 24
Porto Alegre 24
Quito 24
The Dalles 24
Boston 23
Dhaka 23
Naples 23
Changchun 22
Turin 22
Manchester 21
Totale 25.871
Nome #
Autophagy and mitophagy elements are increased in body fluids of multiple sclerosis-affected individuals 295
A Commentary on the Use of Epstein-Barr Virus Specific Antibodies as Biological Markers in Multiple Sclerosis 283
Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study 282
Multiple Sclerosis in Italy: A 40-Year Follow-Up of the Prevalence in Ferrara 274
Epidemiological Study of Huntington's Disease in the Province of Ferrara, Italy 256
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 250
Autophagy and mitophagy biomarkers are reduced in sera of patients with Alzheimer's disease and mild cognitive impairment 238
Incidence of childhood and adolescence epilepsy: a community-based prospective study in the province of Ferrara and in Copparo, Italy, 1996-2005 219
A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q) 217
Epidemiological health and social study on multiple sclerosis in the Ferrara province 217
Case Report: A Case of Creutzfeldt-Jakob Heidenhain Variant Simulating PRES 211
Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis 205
An epidemiological study of multiple sclerosis in central Sardinia, Italy 195
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 194
Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study 190
Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study 189
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study 189
Different roles of mitochondria in cell death and inflammation: Focusing on mitochondrial quality control in ischemic stroke and reperfusion 187
Acceptability and cross-cultural feasibility of it self-administered questionnaire on past exposure to putative environmental risk factors for multiple sclerosis 186
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 185
Epidemiological studies of multiple sclerosis in a Sardinian population, insular Italy. Cluster studies and health status 182
Multiple sclerosis in the Republic of San Marino, Italian peninsula: an incidence and prevalence study from a high-risk area 182
A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD 180
A genome screen for multiple sclerosis in Sardinian multiplex families 179
Time perception in cerebellar and basal ganglia stroke patients 179
Negative interaction between smoking and infectious mononucleosis in the risk of MS 177
Environmental and genetic factors in pediatric inflammatory demyelinating diseases 177
Decision-Making in Multiple Sclerosis Consultations in Italy: Third Observer and Patient Assessments 175
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 174
Transorbital Ultrasonography and Doppler Ultrasound to investigate Optic Nerves in Multiple Sclerosis 173
A need for national registries and international collaborative research in multiple sclerosis 172
International case control study on risk factors for multiple sclerosis (MS): pilot testing the questionnaire 169
Transorbital Ultrasound for Morphological and Haemodynamical Assessment of Optic Nerve in Multiple Sclerosis 167
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients 166
The high prevalence of hereditary spastic paraplegia in Sardinia, insular Italy 166
Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein–Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study 163
Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study 163
People with MS should consume a low-salt diet - Commentary 161
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 160
Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study 160
Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: Implications for mortality studies 160
An evaluation of quantitative env and qualitative pol rt-pcr detection of the multiple sclerosis (MS) -associated retrovirus in Europe 159
Specific antibodies reacting to JC polyomavirus capsid protein mimotopes in sera from multiple sclerosis and other neurological diseases-affected patients 159
An overview of pregnancy-related issues in patients with multiple sclerosis 158
The EnvIMS study: Design and methodology of an international case-control study of environmental risk factors in multiple sclerosis 157
Multiple sclerosis associated with syringomyelia 157
Cognition in Patients with Spinocerebellar Ataxia 1 (SCA1) and 2 (SCA2): A Neurophysiological and Neuropsychological Approach 156
Smaller optic nerve diameters and reduced flow velocity of ophthalmic artery suggest a history of optic neuritides: Transorbital Ultrasonography and Doppler Ultrasound in multiple sclerosis 155
Age at onset in multiple sclerosis 155
Reversible cerebral vasoconstriction syndrome: strategies to early diagnosis and the role of transcranial color-coded doppler ultrasonography (TCCD) 153
Amyotrophic Lateral Sclerosis and Air Pollutants in the Province of Ferrara, Northern Italy: An Ecological Study 153
Easycall corpus: A dysarthric speech dataset 153
The Diagnostic Utility of Oligoclonal Bands in Multiple Sclerosis: A Time-Course Analysis 152
Cost of disorders of the brain in Italy 152
Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients 152
A trial to prove the efficacy of acupuncture as a therapeutic support in pharmacological prophylaxis for migraine and tension-type headache. Pilot study 152
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 151
Multiple sclerosis in the Republic of Moldova: a descriptive study of prevalence and evolution of clinical manifestations 150
Cost of disorders of the brain in Europe 2010 149
Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995-2009 149
The Incidence of Myasthenia Gravis in the Province of Ferrara, Italy, in the Period of 2008–2022: An Update on a 40-Year Observation and the Influence of the COVID-19 Pandemic 149
A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study 148
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study 148
Pediatric recurrent acute necrotizing encephalomyelitis, RANBP2 genotype and Sars-CoV-2 infection: Diagnosis, pathogenesis and targeted treatments from a case study 147
3rd Alghero International Conference on Multiple Sclerosis, Pathogenesis and Treatment 147
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 147
Cerebral Venous Thrombosis during Thyrotoxicosis: Case Report and Literature Update 146
An evaluation of quantitative env and qualitative pol rt-pcr detection of the multiple sclerosis (MS) -associated retrovirus in Europe 146
The burden of multiple sclerosis variants in continental Italians and Sardinians 146
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS 145
Frontotemporal Dementia, Where Do We Stand? A Narrative Review 144
Alpha B-crystallin is not a dominant peripheral T-cell autoantigen in multiple sclerosis amongst Sardinians 144
Estimation of the cost of MS in Europe – Extrapolations from a multinational cost study 143
An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus 143
Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis 142
Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study 142
Pudendal nerve SEP in possible and probable multiple sclerosis. 141
No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis 141
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 141
Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination 140
Immunogenetic heterogeneity of multiple sclerosis in Sardinia 140
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients 140
An international case-control study of risk factors for multiple sclerosis 140
Sex-Related Differences in Cerebrospinal Fluid Plasma-Derived Proteins of Neurological Patients 140
Neuromuscular transmission impairment and multiple sclerosis. 139
The epidemiology of multiple sclerosis in Europe 139
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review 138
Evidence of early childhood as the susceptibility period in multiple sclerosis. Space-time cluster analysis in a Sardinian population 138
Personality traits predict perceived health-related quality of life in persons with multiple sclerosis 138
Epidemiology of multiple sclerosis 138
The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis 138
The worldwide prevalence of multiple sclerosis 138
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 137
Sex Differences in Albumin Quotient and Cerebrospinal Fluid Total Protein Content Do Not Depend on Anthropometric Factors 137
ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations. 137
Which syringomyelia is truly associated with multiple sclerosis? 137
Multiple sclerosis complexity in selected populations: the challenge of Sardinia, insular Italy 136
Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk 136
Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy 134
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 134
Totale 16.613
Categoria #
all - tutte 202.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.949
Totale 204.679


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021227 0 0 0 0 0 0 0 0 0 0 0 227
2021/20222.114 101 299 173 94 54 67 100 121 82 217 127 679
2022/20232.673 318 97 50 285 498 421 69 324 335 32 160 84
2023/20241.393 155 194 75 38 136 125 55 89 37 78 100 311
2024/20256.315 316 91 534 151 722 361 131 452 1.204 1.153 578 622
2025/202617.739 1.289 657 1.647 2.396 2.222 1.061 1.823 1.187 1.775 2.248 1.068 366
Totale 41.095